Review Note

Last Update: 10/19/2024 05:32 AM

Current Deck: PACES::Conditions

New Card (Unpublished)

Currently Published Content

Text

Extra

No published tags.

Pending Suggestions

Field Change Suggestions:

Text

Commit #178923

Overview of management of myelo/lymphoproliferative disorders

Myeloproliferative
{{c1::Aspirin & cytoreductive therapy (Hydroxyurea) (ET, PRV)
Targeted therapy (Imatinib for CML, Ruxolitinib for MF)
Transfusions (MF) / Phlebotomy (PRV)
Stem cell transplant (CML, MF)}}

Lymphoproliferative
{{c1::Chemotherapy}}